ANTHONIA EGBEDEJU: Open Payments
NPI 1568758829 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 9 payments from 7 companies in 2025. Trend: 2023 $1,391 · 2024 $2,280 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $177 |
| Gilead Sciences, Inc. | 2 | $148 |
| ABBVIE INC. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| Corcept Therapeutics | 1 | $106 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $86 |
| Exact Sciences Corporation | 1 | $22 |
Products named: LINZESS, Epclusa, SHINGRIX, Korlym, BREZTRI, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
